Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia ; volume:13 ; number:1 ; day:20 ; month:6 ; year:2018 ; pages:1-6 ; date:12.2018
Orphanet journal of rare diseases ; 13, Heft 1 (20.6.2018), 1-6, 12.2018
- Urheber
-
Blom, Dirk J.
- Beteiligte Personen und Organisationen
-
Cuchel, Marina
Ager, Miranda
Phillips, Helen
SpringerLink (Online service)
- DOI
-
10.1186/s13023-018-0841-3
- URN
-
urn:nbn:de:101:1-2018083022212968004225
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blom, Dirk J.
- Cuchel, Marina
- Ager, Miranda
- Phillips, Helen
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)